+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mumps Test"

Mumps Diagnostics Market 2024: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies - Product Thumbnail Image

Mumps Diagnostics Market 2024: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

  • Report
  • August 2024
  • Japan, United States, ... Japan, United States, Europe
From
2024-2028 Global Mumps Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2024-2028 Global Mumps Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • October 2024
  • Global
From
2022-2026 Global Mumps Testing in 90 Countries - Product Thumbnail Image

2022-2026 Global Mumps Testing in 90 Countries

  • Report
  • December 2021
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Mumps Test market is a subset of the larger Infectious Disease Testing market. It is composed of tests that detect the presence of mumps virus in a patient's sample. These tests are used to diagnose mumps infection and to monitor the effectiveness of treatment. Tests are available in a variety of formats, including ELISA, PCR, and rapid antigen tests. The Mumps Test market is driven by the prevalence of mumps infection, the availability of effective treatments, and the need for accurate diagnosis. The market is expected to grow as the demand for mumps testing increases. Companies in the Mumps Test market include Abbott, Bio-Rad, DiaSorin, Euroimmun, GenMark Diagnostics, Hologic, Luminex, Quidel, and Siemens Healthineers. Show Less Read more